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Abstract 
 
Breast cancer is the main cause of cancer death among women, especially breast cancer 
metastasis. Metastasis process begins with the ability of cell cancer invasion. Doxorubicin, a 
antracycline chemotheraphy, is known to induce TGFβ1, thus promote invasion. The aim of this 
study is to optimize doxorubicin doses to induce lamellipodia formation in 4T1 and MCF-7/HER2 
cells. Lamellipodia formation was observed by morphological changes using microscope inverted. 
The effect of doxorubicin on cell viability was analyzed using MTT assay. Rac1 expression after 
doxorubicin exposure was determined by western blotting. Lamellipodia formation was observed 
by morphological change of the cell at the dose 10, 25, 50 and 100 nM. Doxorubicin at the dose of 
10 nM could induced lamellipodia formation without affect cell viability in both 4T1 and MCF-
7/HER2 cells.  Doxorubicin induced cell cycle arrest at G2/M phase at all doses. Doxorubicin 10 
nM also decrease Rac1 expression compared to control.  
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INTRODUCTION 
 
Metastasis, one of hallmark of cancer, is 
spreading of cancer cell from primary site to distant 
site. Therapy of cancer metastasis becomes 
challenging and metastasis is the main cause of 
cancer death among patient. Metastasis process 
begin with local invasion, cells detached from 
primary site, increase motility and release proteolytic 
enzyme to degrade extracellular matrix, such as 
serine, cysteine, and metalloprotease (Verma and 
Hansch, 2007). Metastasis was characterized by loss 
of E-cadherin, a molecule involved in cell adhesion 
(Hanahan and Weinberg, 2011). Cell migration 
depend on cell polarization and lamellipodia 
formation via Rac1 cascade. Rac1 activation induce 
actin polymerization and increase cell motility 
(Arpaia, et al., 2012). 
Doxorubicin is widely used as chemotherapy 
in breast cancer. Long-term use of doxorubicin cause 
some side effects leading to reduce chemotherapy 
effectivity. In addition, doxorubicin also induced 
TGFβ1 signaling activity in triple negative receptor 
breast cancer cell type and MDA-MB 231. 
Doxorubicin induced epithelial-mesenchymal 
transition (EMT) and initiate invasion via TGFβ1 
signaling. Thus, doxorubicin could induce cell 
migration to distant site. On the other hand, 
activation of TGFβ1 signaling also generate stem-
like breast cancer cell and increase drug resistance 
(Bandyopadhyay, et al., 2010). The aim of this study 
is to optimize doxorubicin doses to induce 
lamellipodia formation on 4T1 and MCF-7/HER2 
cells. 
 
METHODS 
 
Cell Culture 
Breast cancer cell line culture type 4T1 
(originally from ATCC
R
-CRL-2539
TM
) and 
MCF7/HER2 were obtained from Prof. Masashi 
Kawaichi (Nara Institute of Science and Technology, 
NAIST, Japan). The cells were maintained in 
Dulbecco’s Modifies Eagles medium (DMEM) high 
glucose (Sigma) supplemented with 10% FBS 
(Sigma), HEPES, sodium bicarbonate, 1.5% 
Penicilin-Streptomycin and 0.5% Fungizone 
(Gibco). Cells were cultured with 5% CO2 in 37
o
C. 
 
Doxorubicin Sample Preparation 
Doxorubicin was dissolved in DMSO 
(Sigma), and freshly diluted in culture medium in 
several concentrations before used. 
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Morphologycal Lamellipodia Formation 
Murine 4T1 cells were treated with 
doxorubicin (10, 25, 50, and 100 nM) for 96 hours. 
The medium with doxorubicin was changed every 
alternate day. Representative pictures of lamellipodia 
formation detected by inverted microscopy (x100 
magnification) (Bandyopadhyay, et al., 2010). 
 
Proliferation Assay  
Approximately 2x10
3 
4T1 cells/well and 
MCF-7/HER2 2.5x10
3 
4T1 cells/well were seeded in 
96-well plates and incubated for 24 hours. Cells 
were treated with increasing concentration of 
doxorubicin (10, 25, 20, and 100 nM) for 24, 48, and 
72 hours. Cultured medium was removed and cells 
were washed with PBS (Sigma). MTT 0.5 mg/mL in 
medium were added into each well and incubated for 
3-4 hours. MTT reaction was stopped by the addition 
of SDS 10% in HCl 0.01 N, and incubated overnight 
in the dark room. The absorbance was measured 
using ELISA reader at λ 595 nm (Merck ELISA 
reader). Each treatment were carried out in triplicate, 
and the absorbance data were provided as percent 
viability compared to control cells (untreated) 
(Mosmann, 1983). 
 
Cell Cycle Analysis 
The 4T1 cells (7.5x10
4
 cells) were seeded in 
6-well plate and incubated for 24 hours. Cell were 
treated with doxorubicin 10, 25, 50 and 100 nM for 
24 hours After the treatment, cells were harvested by 
trypsinization and stained with the staining solution 
contains propidium iodide (PI) 1 mg/mL protease 
inhibitor, 10 mg/mL RNAse and 0,1% (v/v) Triton 
X-100 (Merck). Cells were incubated for 5 minutes 
in the dark room, transferred into a ﬂow cytometric 
tube and analyzed by BD FACS Calibur (BD 
Bioscience, USA). Cell cycle distribution was 
acquired by using Flowing software. 
 
Western Blot 
Approximately 4x10
3
 4T1 cells and 3x10
3
 
MCF-7/HER2 cells were seeded in 6-well plates, and 
incubated for 24 hours. Cell were treated with 
doxorubicin 10, 25, 50 and 100 nM for 48 hours. 
Protein was extracted using  radio immune 
precipitation assay (RIPA) buffer (Tris HClpH 7.6, 
NP 40, Na-deoxycholate, NaCl, SDS, phenyl methyl 
sulfonyl flouride (PMSF), NaF, and cocktail 
inhibitor protease, then separated in 14% acrylamide 
gel by SDS-PAGE electrophoresis. After transferring 
to polyvinylidene fluoride (PVDF) membrane, the 
membrane was incubated overnight at 4°C with 
either the mouse monoclonal antibody against Rac1 
(Santa Cruz cs22475) or β-actin (Santa Cruz sc-
47778). After incubation with secondary antibody 
anti-mouse (Santa Cruz sc-516102) for 1 hour, the 
protein bands were visualized using ECL 
(Amersham) and detected using Luminograph. The 
relative protein levels were calculated in reference to 
the amount of β-actin protein. 
 
RESULTS 
 
The Effect of Doxorubicin in Cells 
Proliferation 
The cytotoxic drug doxorubicin is a well-
known chemotherapeutic agent which is used in 
treatment of a wide variety of cancers inducing 
intracellular ROS accumulation, cell cycle arrest and 
apoptosis. However, doxorubicin treatment is often 
hampered by severe side effects and resistance of 
cancer cells to therapy. To determine the effect of 
doxorubicin in inducting lamellipodia formation on 
4T1 and MCF-7/HER2 cells, firstly we examined the 
cytotoxic effect of doxorubicin at different 
concentrations (0, 10, 25, 50 and 100 nM) for 0, 24, 
48 and 72 hours by MTT assay. As shown in Fig. 1, 
doxorubicin demonstrated a cytotoxic effect on 4T1 
and MCF-7/HER2 cells. Doxorubicin reduced the 
viability on both of cells in a dose-dependent and a 
time-dependent manner. 
 
 
Effect of Doxorubicin on Cell Cycle 
Modulation 
In order to investigate the mechanism of 
physicological changes focusing on cell cycle, the 
cells were processed for flowcytometry by PI 
staining. Our study showed that cell proliferation 
was affected by doxorubicin treatment with 
concentration dependent manner. Furthermore, cell 
cycle analysis was elaborated to understand the 
modulation of cell proliferation through cell cycle 
alteration. Here, we found that doxorubicin treatment 
conducted cell to perform G2/M arrest and increase 
accumulation of sub-G1 phase cells (Fig. 2). The 
highest effect of cell cycle alteration showed in 25 
nM doxorubicin treatment in both phase. 
Interestingly, the cell percentage of each phase was 
different. Whereas, the 10 nM of doxorubicin gave 
similar proliferation effect, similar to the control. 
Hence, it needed to explore further about the 
morphological alteration due to different 
concentration of doxorubicin. 
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Figure 1. Proliferation effect of Doxorubicin (Doxo) on cell viability. A. Proliferative assay of Doxo 10, 25, 50, and 100 
nM on 4T1 cells. B. Proliferative assay of Doxo 10, 25, 50, and 100 nM on MCF-7/HER2 cells. Proliferative assay was 
determined by MTT assay as described in the methods. Cell was treated with various concentration of Doxo for 24, 
48, and 72 hours. Cell viability after treatment was compared to baseline. Each experiment was conducted in 
triplicate. Mean values from the three experiments ± standard error of mean are shown. 
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Figure 2. Effects of Doxorubicin on Cell Cycle Modulation on 4T1 Cells. Cells were harvested after 24 h of treatment, 
stained with propidium iodide and DNA content were analyzed by using ﬂowcytometry. (A) The profiles of cells in 
the phases of sub-G1, G1, S and G2-M (i) control cells, (ii) doxorubicin 10 nM, (iii) doxorubicin 25 nM, (iv) 
doxorubicin 100 nM. X-axis showed the relative content of DNA and the Y axis showed the relative cell numbers. 
(B) Quantification of cells distribution in each phase (Sub G0/G1, G1, S, and G2/M phase) of the various treatments. 
The percentage of sub-G1 phase cells showed apoptotic cell population. 
 
Effect of Doxorubicin on Lamellipodia 
Formation 
Lamellipodia formation is beginning step of 
cell migration, thus effect of doxorubicin on 
lamellipodia formation was observed. The cells were 
treated using doxorubicin at the dose of 10, 25, 50, 
and 100 nM. Lamellipodia formation was observed 
at 0, 24, 48, 72, and 96 hours after treatment (Fig. 3). 
Change of cell morphology also observed. 
Lamellipodia of 4T1 cells was observed even at 
lowest doses (10 nM) after 24 hours treatment. 
Meanwhile lamellipodia of MCF-7/HER2 cells was 
observed at the doses of 25 nM after 24 hours 
treatment. Prolong exposure of doxorubicin on both 
cells after 96 hours treatment affect cell morphology 
leading to cell death. 
Effect of Doxorubicin on Rac1 Expression 
Rac1 is protein involved in rearrangemnet of 
actin and lamellipodia formation.  To understanding 
whether lamellipodia formation were affected by 
Rac1 expression, thus Rac1 expression was 
observed. Rac1 expressions of 4T1 and MCF-
7/HER2 after treatment with doxorubicin 10 nM was 
examined using western blot. doxorubicin 10 nM 
reduced Rac1 expression in both  4T1 and MCF-
7/HER2 cells (Fig. 4). Due to this result, we 
understood that the formation of lamellipodia was 
different on both cell yet the treatment of 10 nM 
doxorubicin brought similar effect on Rac1 
expression. 
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Figure 3. Induction of lamellipodia formation by Doxorubicin (Dox). (A) on 4T1 cells, (B) on MCF-7/HER2 cells. 
Representative pictures of 4T1 cells with mesenchymal morphology after treatment with untreated cells, Dox 10 
nM, Dox 25 nM, Dox 50 nM and Dox 100 nM. Shown is confocal microscopy of the lamellipodia (100x 
magnification). Arrows indicate cells morphological changes. 
A 
 
B 
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Figure 4.  Rac-1 Protein Expression under Doxorubicin (Doxo). (A) 4T1 cell and (B) MCF-7/HER2 after 
treatment with Doxo 10 nM. Expression was compared between control (untreated) and Doxo treatment. 
Rac1 expression was observed with western blot shown different expression between groups. The levels of 
Expression were normalized by comparing with β-actin expression level 
DISCUSSION 
 
Doxorubicin is usually for first-line treatment 
of several type cancer. Drug chemosensitivity have 
been investigated in the several models of breast 
cancer cell such as T47D, WiDr colon cancer cells, 
MCF-7, MCF-7/Dox and showed various cytotoxic 
effects (Febriansah, et al., 2014; Hermawan, et al., 
2010; Putri, et al., 2016). This study explored the 
effect of doxorubicin on triple negative breast cancer 
cell, 4T1, that is highly metastasis in breast and 
HER2-overexpresed cell, MCF-7/HER2. The results 
of our cytotoxicity assay, doxorubicin inhibited cell 
growth in a dose-dependent and a time-dependent 
manner on 4T1 and MCF-7/HER2. Previous study 
reported the cytotoxic mechanism of doxorubicin 
was through disruptions topoisomerase II, resulting 
in DNA damage and cell death (Rowan, 1979). 
Based on the result of cytotoxic effect of 
doxorubicin. This present study was continued to 
investigate possibility pathway in growth cells 
inhibition through cell cycle modulation. This study 
showed that doxorubicin inhibited 4T1 breast cancer 
cell growth through cell cycle modulation. Three 
concentration of doxorubicin caused cell 
accumulation in G2/M phase. Similar results were 
performed by previous studies that had been reported 
Putri, et al (2017) which showed doxorubicin could 
inhibit the growth of T47D cells by an accumulation 
of cells at the G2/M phase.  
In this present study inhibition of cancer 
metastasis after treatment of doxorubicin was also 
observed. Cell migration is part of the process of 
metastasis. Interestingly, prolong use of doxorubicin 
exhibit several limitation such as toxicity and cancer 
cell resistance. On the other hand, doxorubicin 
activates TGF-β signalling in breast cancer cells 
which is increasing of TGF-β involved in 
mallignancies, such as metastatic breast cancer 
progression and survival. These also induce cancer 
cell migration and invation. Activation of TGF-β 
also induce Ephitelial-Mesencymal transition that 
increase cell motility and invasiveness 
(Bandyopadhyay, et al., 2010). The ability of cell to 
migrate involved formation of lamellipodia. The 
result of this study showed that low doses of 
doxorubicin could induced lamellipodia formation. 
Doxorubicin at low doses induced lamellipodia 
formation both in 4T1 and MCF-7/HER2 cell 
observed begin at 24 hours after treatment. This 
phenomenon was caused by doxorubicin ability to 
activate TGF-β leading to activation of Smad2 and 
Smad3. Increasing of Smad2 and Smad3 induce 
EMT, thus enhanced cell migration. In addition, 
activation of Erk MAP kinase, Rho GTPase and PI3 
kinase/Akt pathway followed by TGF-β also induced 
cell growth, migration, and invasion (Xu, et al., 
2009). Extension of lamellipodia was needed by cell 
to move on certain direction. Thus, observation of 
lamellipodia formation can be used as parameter to 
observed cell migration. 
Rac1 is family of Rho GTPase protein that 
involved in cellular dynamic, particularly 
lamellipodia that initiate migration of cell (Ehrlich, 
Amalina, et al., 2017 
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et al., 2002). Nevertheless, Rac1 is not the only 
protein that regulate actin structures, RhoG or Cdc42 
also play role in these structure (Steffen, et al., 
2013). In this study, doxorubicin reduce Rac1 
expression of 4T1 and MCF-7/HER2 cells. These 
result indicate that lamellipodia formation on those 
cell did not dependent to Rac1 expression.  Rab5, a 
member of Rab family of GTPase, triggered 
lamellipodia formation independent with receptor 
tyrosine kinase/Ras/PI3-K/Rac pathways 
(Spaargaren and Bos, 1999). However, further study 
need to be conducted to confirm whether this 
phenomenon involved Rab5 activity.  
 
CONCLUSION 
 
Doxorubicin could inhibits cells growth by 
induced G2/M cell cycle arrest and the other hand 
doxorubicin induce epithelial mesenchymal 
transition through Rac1 independent-lamellipodia 
formation. 
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